CIK 0001094038
- Non-accelerated filer
- Smaller reporting company
Marker Therapeutics, Inc.
Sign in to watch- Ticker
- MRKR
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- Operating
- EIN
- 880277072
- Phone
- +1 713-400-6400
- Business address
- 2450 HOLCOMBE BLVD, TMC PARTNERS OFFICE 1.311, HOUSTON, TX, 77021
- Former names
- TAPIMMUNE INC., TAPIMMUNE INC, GENEMAX CORP, EDUVERSE COM
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $0
- in 0 filings
Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Reading 58 more Form 4s from the SEC; this list fills in as they're read.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2023-02-27 | Koneru Mythili Chief Medical Officer | Grant or award · Employee Stock Option (right to buy) | +51,918 | 51,918 | ||
| 2023-02-27 | Loiacono Michael Chief Accounting Officer | Grant or award · Employee Stock Option (right to buy) | +38,480 | 38,480 | ||
| 2023-02-27 | Vera Juan Chief Scientific Officer & COO | Grant or award · Employee Stock Option (right to buy) | +46,487 | 46,487 | ||
| 2023-02-27 | Szymanska Anna Vice President, Quality | Grant or award · Employee Stock Option (right to buy) | +29,947 | 29,947 | ||
| 2023-02-27 | Agopyan Nadia SVP, Regulatory Affairs | Grant or award · Employee Stock Option (right to buy) | +34,154 | 34,154 | ||
| 2022-05-24 | Wilson John Robert Director | Grant or award · Stock Option (Right to Buy) | +80,000 | 80,000 | ||
| 2022-05-24 | Laskow-Pooley David Director | Grant or award · Stock Option (Right to Buy) | +80,000 | 80,000 | ||
| 2022-05-24 | Knobil Katharine Director | Grant or award · Stock Option (Right to Buy) | +80,000 | 80,000 | ||
| 2022-05-24 | ELMS STEVE Director | Grant or award · Stock Option (Right to Buy) | +80,000 | 80,000 | ||
| 2022-05-24 | Eansor Norman David Director | Grant or award · Stock Option (Right to Buy) | +80,000 | 80,000 | ||
| 2022-03-24 | Hoang Peter L. President and CEO | Grant or award | +199,094 | 531,662 | ||
| 2022-03-24 | Hoang Peter L. President and CEO | Shares withheld for taxes | −48,376 | $0.48 | $23K | 483,286 |
| 2022-03-24 | Vera Juan Chief Scientific Officer & COO | Grant or award | +140,823 | 2,705,310 | ||
| 2022-03-24 | Vera Juan Chief Scientific Officer & COO | Shares withheld for taxes | −33,465 | $0.48 | $16K | 2,671,845 |
| 2022-03-24 | Kim Anthony H. Chief Financial Officer | Grant or award | +150,512 | 150,512 | ||
| 2022-03-24 | Kim Anthony H. Chief Financial Officer | Shares withheld for taxes | −36,076 | $0.48 | $17K | 114,436 |
| 2022-02-17 | Hoang Peter L. President and CEO | Grant or award · Employee Stock Option (right to buy) | +430,000 | 430,000 | ||
| 2022-02-17 | Vera Juan Chief Scientific Officer & COO | Grant or award · Employee Stock Option (right to buy) | +160,000 | 160,000 | ||
| 2022-02-17 | Szymanska Anna Vice President, Quality | Grant or award · Employee Stock Option (right to buy) | +40,000 | 40,000 | ||
| 2022-02-17 | Loiacono Michael Chief Accounting Officer | Grant or award · Employee Stock Option (right to buy) | +140,000 | 140,000 |
Page 2 of 6 · 119 trades